Analyst Research Roundup: Research Frontiers Incorporated (REFR), MoSys, Inc. (MOSY)

Research Frontiers Incorporated (NASDAQ:REFR) tinted loss of -3.36% (-0.1 points) to US$2.87. The volume of 0.72 Million shares climbed down over an trading activity of 87.67 Million shares. EPS ratio determined by looking at last 12 month figures is -0.11. Over the same time span, the stock marked US$3 as its best level and the lowest price reached was US$0.6. The corporation has a market cap of US$83.96 Million.

Research Frontiers Incorporated (NASDAQ:REFR)’s earnings per share has been growing at a 8.6 percent rate over the past 5 year when average revenue increase was noted as -5.1 percent. The return on equity ratio or ROE stands at -91 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 12.3 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 2. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

MoSys, Inc. (NASDAQ:MOSY) is worth US$7.96 Million and has recently risen 15.8% to US$0.21. The latest exchange of 6 Million shares is above its average trading activity of 1.29 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$2.23 while the mean 12-month price target for the shares is US$1.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0.26, and a price to sales ratio of 0.47. For the past 5 years, the company’s revenue has grown 7.8%, while the company’s earnings per share has grown 6.3%. With an institutional ownership near 15.8%, it carries an earnings per share ratio of -3.62.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 1 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 0 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.